[Intestinal malperfusion in critical care patients]

G Knichwitz1, C Kruse, H van Aken

  • 1Klinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Münster. knichwi@uni-muenster.de

Der Anaesthesist
|October 14, 2004
PubMed

Insights

Intestinal malperfusion, including non-occlusive mesenteric ischemia (NOMI), is a severe condition requiring early diagnosis in critical care. This review covers its pathophysiology, diagnosis, and management strategies for better patient outcomes.

Area of Science:

  • Gastroenterology and Critical Care Medicine
  • Pathophysiology of Ischemic Conditions

Context:

  • Intestinal malperfusion is a critical illness with high mortality, often complicating other diseases, surgery, or invasive therapies.
  • Non-occlusive mesenteric ischemia (NOMI) is increasingly significant in intensive care settings.
  • Critical care patients may present with subtle or absent clinical symptoms, necessitating heightened vigilance.

Purpose:

  • To review the pathophysiology of intestinal malperfusion and non-occlusive mesenteric ischemia (NOMI).
  • To discuss diagnostic challenges and methods for early detection in critically ill patients.
  • To outline therapeutic and preventive strategies for managing intestinal malperfusion.

Summary:

  • Intestinal malperfusion, exacerbated by the bowel's sensitivity to hypoxia, poses a grave threat, particularly NOMI in critical care.
  • Early diagnosis is crucial for prognosis, as clinical signs can be obscured in critically ill patients.
  • The review synthesizes current knowledge on the mechanisms, detection, and management of this condition.

Impact:

  • Improved understanding of NOMI pathophysiology aids in developing targeted diagnostic and therapeutic approaches.
  • Emphasis on early diagnosis can lead to timely intervention, potentially reducing mortality rates.
  • Comprehensive review provides a valuable resource for intensivists managing patients at risk of intestinal malperfusion.